| Mrs Alison Blount Powell, APRN BC | |
|
336 Georgia Ave, Ste 106, North Augusta, SC 29841-3887 | |
| (803) 279-1412 | |
| (803) 279-2858 |
| Full Name | Mrs Alison Blount Powell |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 19 Years |
| Location | 336 Georgia Ave, North Augusta, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295833176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | RN150666 (Georgia) | Secondary |
| 363L00000X | Nurse Practitioner | 2724 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospital | Augusta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Group Llc | 2567640915 | 25 |
| Piedmont Professional Services Llc | 8921176231 | 120 |
| Umg Prompt Care South Carolina Llc | 9830401660 | 26 |
| Piedmont Professional Services Llc | 8921176231 | 120 |
News Archive
High blood pressure appears to predict the progression to dementia in older adults with impaired executive functions (ability to organize thoughts and make decisions) but not in those with memory dysfunction, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
A team of researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC), report that primary care providers (PCP) fail to report a substantial number of cases of child maltreatment.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
› Verified 3 days ago
| Entity Name | University Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871885806 PECOS PAC ID: 2567640915 Enrollment ID: O20110803000008 |
News Archive
High blood pressure appears to predict the progression to dementia in older adults with impaired executive functions (ability to organize thoughts and make decisions) but not in those with memory dysfunction, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
A team of researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC), report that primary care providers (PCP) fail to report a substantial number of cases of child maltreatment.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
› Verified 3 days ago
| Entity Name | Umg Prompt Care South Carolina Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629462122 PECOS PAC ID: 9830401660 Enrollment ID: O20150707002716 |
News Archive
High blood pressure appears to predict the progression to dementia in older adults with impaired executive functions (ability to organize thoughts and make decisions) but not in those with memory dysfunction, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
A team of researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC), report that primary care providers (PCP) fail to report a substantial number of cases of child maltreatment.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
› Verified 3 days ago
| Entity Name | Piedmont Medical Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912956046 PECOS PAC ID: 6002802220 Enrollment ID: O20240126001874 |
News Archive
High blood pressure appears to predict the progression to dementia in older adults with impaired executive functions (ability to organize thoughts and make decisions) but not in those with memory dysfunction, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
A team of researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC), report that primary care providers (PCP) fail to report a substantial number of cases of child maltreatment.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
› Verified 3 days ago
| Entity Name | Piedmont Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104088905 PECOS PAC ID: 8921176231 Enrollment ID: O20240213001704 |
News Archive
High blood pressure appears to predict the progression to dementia in older adults with impaired executive functions (ability to organize thoughts and make decisions) but not in those with memory dysfunction, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
A team of researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC), report that primary care providers (PCP) fail to report a substantial number of cases of child maltreatment.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Alison Blount Powell, APRN BC Po Box 1705, Augusta, GA 30903-1705 Ph: (706) 774-7263 | Mrs Alison Blount Powell, APRN BC 336 Georgia Ave, Ste 106, North Augusta, SC 29841-3887 Ph: (803) 279-1412 |
News Archive
High blood pressure appears to predict the progression to dementia in older adults with impaired executive functions (ability to organize thoughts and make decisions) but not in those with memory dysfunction, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
A team of researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC), report that primary care providers (PCP) fail to report a substantial number of cases of child maltreatment.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
› Verified 3 days ago
Ashley Marie Dickert, PNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 140 Allen Court, North Augusta, SC 29860 Phone: 803-510-0007 | |
Kimberly Emia May, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 22 Burning Tree Pl, North Augusta, SC 29860 Phone: 478-456-0003 | |
Linsey Caines, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 104 Walnut Ln Ste 101, North Augusta, SC 29860 Phone: 803-599-7680 Fax: 949-695-2162 | |
Mrs. Alyssa Megan Taylor Hodge, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 Edgefield Rd, North Augusta, SC 29841 Phone: 803-426-8882 | |
Charlaine Conger, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 105 Lake Murray Dr, North Augusta, SC 29841 Phone: 803-292-9250 | |
Amanda Byers, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 Edgefield Rd, North Augusta, SC 29841 Phone: 803-426-8882 | |
Mrs. Courtney Mclendon, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 140 Allen Court, North Augusta, SC 29860 Phone: 803-510-0007 Fax: 803-510-0144 |